Probi
Researches, develops, and manufactures clinically documented probiotic strains.
PROB | ST
Overview
Corporate Details
- ISIN(s):
- SE0001280355
- LEI:
- 5493004CJOCT273MU397
- Country:
- Sweden
- Address:
- Ideongatan 1A, 223 70 Lund
- Website:
- https://www.probi.com/
- Sector:
- Manufacturing
Description
Probi is a global biotics company specializing in the research, development, and manufacturing of clinically documented probiotic strains. The company provides biotic solutions for dietary supplements and functional foods, targeting specific health needs across various life stages. Its portfolio addresses key areas such as digestive, immune, mental, and metabolic health, alongside specialized formulations for women, children, and healthy aging. Probi's offerings are founded on extensive scientific research and clinical studies to ensure proven efficacy in supporting human health.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-02-03 09:20 |
Avnotering av Probi
|
Swedish | 99.1 KB | ||
| 2025-02-03 09:20 |
Delisting of Probi
|
English | 103.2 KB | ||
| 2025-01-22 15:55 | Swedish | 9.1 KB | |||
| 2025-01-21 09:47 | Swedish | 8.9 KB | |||
| 2025-01-20 22:01 |
Notice of Extraordinary General Meeting in Probi AB (publ)
|
English | 123.5 KB | ||
| 2025-01-20 22:01 |
Kallelse till extra bolagsstämma i Probi AB (publ)
|
Swedish | 82.2 KB | ||
| 2025-01-20 22:00 |
Probi applies for delisting and convenes an Extraordinary General Meeting
|
English | 109.7 KB | ||
| 2025-01-20 22:00 |
Probi ansöker om avnotering och kallar till extra bolagsstämma
|
Swedish | 104.6 KB | ||
| 2025-01-09 08:00 |
Probi senarelägger bokslutskommuniké för 2024
|
Swedish | 92.1 KB | ||
| 2025-01-09 08:00 |
Probi postpones year-end report 2024
|
English | 81.1 KB | ||
| 2025-01-09 08:00 |
Probi senarelägger bokslutskommuniké för 2024
|
Swedish | 92.1 KB | ||
| 2025-01-09 08:00 |
Probi postpones year-end report 2024
|
English | 81.1 KB | ||
| 2024-12-13 17:18 |
Statement from the independent bid committee of Probi in relation to the public…
|
English | 142.9 KB | ||
| 2024-12-13 17:17 |
Uttalande från den oberoende budkommittén i Probi med anledning av Symrise offe…
|
Swedish | 140.4 KB | ||
| 2024-11-20 07:20 |
Probi’s Board comments on Symrise’s public takeover offer
|
English | 101.9 KB |
Automate Your Workflow. Get a real-time feed of all Probi filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Probi
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Probi via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-30 | Jean-Yves Parisot | Other | Buy | 142,586 | 49,905,100.00 SEK |
| 2024-11-22 | Jean-Yves Parisot | Other | Buy | 42,076 | 14,726,600.00 SEK |
| 2024-11-21 | Jean-Yves Parisot | Other | Buy | 77,405 | 27,091,750.00 SEK |
| 2024-11-20 | Jean-Yves Parisot | Other | Buy | 169,053 | 59,168,550.00 SEK |
| 2022-05-06 | Henrik Lundkvist | Other | Buy | 100 | 27,981.00 SEK |
| 2022-04-29 | Tom Rönnlund | Other | Buy | 400 | 122,296.00 SEK |
| 2022-04-28 | Tom Rönnlund | Other | Buy | 955 | 287,015.70 SEK |
| 2020-05-06 | Tom Rönnlund | Other | Buy | 400 | 100,000.00 SEK |
Peer Companies
